CJC-1295 is the primary topic on Retapedia for the
terms listed below. This page distinguishes other meanings and
related entries.
CJC-1295 (also called CJC-1295, DAC:GRF, CJC-1295 with DAC, CJC-1295 without DAC, Modified GRF 1-29) may refer to:
Primary topic
- CJC-1295 — Increases growth hormone and IGF-1 for 6+ days per injection. Improves body composition, muscle recovery, and fat metabolism. Weekly dosing.
Also known as
The following names are catalogued aliases for the primary topic:
- CJC-1295
- DAC:GRF
- CJC-1295 with DAC
- CJC-1295 without DAC
- Modified GRF 1-29
Related entries on Retapedia
- Sermorelin — Stimulates the pituitary to release growth hormone and IGF-1 under normal feedback control. FDA-approved for GH deficiency; used off-label for anti-aging via nightly injection.
External meanings
The term CJC-1295 may carry meanings outside this catalogue — for example, as a developmental code shared with an unrelated chemical entity, or as a trademarked product name in a different therapeutic area. Retapedia does not catalogue non-peptide compounds; consult an external reference such as PubChem or Wikidata for broader coverage.
Categories:
Disambiguation pages